Brain Implant Therapeutics (BIT) Pharma was founded in November 2015 by leaders from academia and industry. The company resides in Graz, Austria. BIT Pharma develops and commercializes technologies for site-specific drug delivery to the central nervous system (CNS), in particular the brain, exploiting tailored drug delivery systems.
R&D:BIT Pharma development strategy focus on tailored and innovative drug delivery systems to be used in highly specialized neurosurgical centres, addressing life-threatening conditions / diseases with high unmet medical needs. These are characterized by small populations with high morbidity, that usually receive little attention from large Pharma Companies, despite the fact that pharmacological solutions may exist through the application of novel drug delivery technology.